Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$5.2 - $28.5 $419,452 - $2.3 Million
-80,664 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$6.7 - $11.8 $45,888 - $80,818
-6,849 Reduced 7.83%
80,664 $58,000
Q1 2019

May 15, 2019

BUY
N/A
7,611 Added 9.53%
87,513 $382,000
Q4 2018

Feb 15, 2019

BUY
N/A
75,379 Added 1666.57%
79,902 $417,000
Q3 2018

Nov 15, 2018

BUY
N/A
4,523 New
4,523 $34,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $72.5M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.